explore -WSS

explore

author：fashion 2025-09-30 17:46:15 - browse：4

Anna Yeo/STAT

Recently approved gene therapies offer patients one-time, potentially curative treatments for genetic diseases such as sickle cell anemia and beta thalassemia. But “one-time” miracle solutions can often be multi-month affairs, require millions of dollars, and cause painful side effects. What if that doesn’t have to be the case?

In utero gene editing, or prenatal somatic cell genome editing, envisions treating a fetus diagnosed with a genetic disease before birth, thereby preventing that entire protocol and the onset of symptoms in the first place. It would also challenge the need for the ethically fraught enterprise of embryo editing, as the treatment would only make edits in the DNA of the individual fetus — edits which would not be passed on in a heritable way.

Watch this video to learn more about in utero gene editing, how it works, and why scientists believe it might be an advantageous approach to treating certain genetic diseases.

Previous article： Duchenne breakthrough therapy leaves behind pioneering families
Next article： ASCO Daily Recap: Safety data from Novartis, survival from Pfizer

focus

WSS

First Opinion Podcast: How to protect health care in times of war

Meta's Zuckerberg and Chan on track to put $50 billion into science

Chimpanzees, like humans and whales, get menopause: Study

ASCO: Palliative care found as helpful given virtually as in person

Ionis drug prevents swelling attacks due to hereditary angioedema

NIH documents show early flaws of $1.6 billion long Covid program

leisure time

explore

entertainment

Cancer drug shortages should be causing more outrage

CDC recommends rationing of RSV shot due to shortages

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Readout Newsletter: XBI biotech index, Akero Therapeutics

New air purifier tech could be key to improving indoor air quality

ASCO: AstraZeneca says CAR

As demand for Covid shots wanes, Moderna seeks its next success

See how much Covid

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

ASCO Daily Recap: Safety data from Novartis, survival from Pfizer

hotspot

Traditional Chinese medicine benefits explored in new JAMA study

Testing for cancer recurrence creates a new limbo for patients

Shifting the focus from loneliness to social health

STAT Wunderkinds: Ruey Hu's digital tools for parsing research

An exit interview with Bristol Myers Squibb CEO Giovanni Caforio

At ASCO, pharma leaders speak of advances in 'smart bomb' drugs

Wikipedia

leisure time

focus

Wikipedia